Identified as the 16th leading cause of death worldwide in 2016, CKD is predicted to become the fifth leading cause of death by 2040 2. Tests and treatments for early-stage CKD are relatively ...

A new meta-analysis published in the recent issue of Clinical Kidney Journal revealed a significant bidirectional ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

Some 20% to 30% of gout patients also have CKD, the researchers said, which is not surprising since they share many risk ...

USA: A recent database study has highlighted a concerning trend in patients suffering from chronic kidney disease (CKD), ...

Researchers at Ulster University’s Personalised Medicine Centre in Derry have made a significant breakthrough in healthcare ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

The safety of left atrial appendage occlusion (LAAO) device implantation in patients with CKD has been uncertain and tied with complications.

In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as compared with bisphosphonates among women with osteoporosis in the ...